Literature DB >> 18358989

gamma-Hydroxybutyric acid (GHB) suppresses alcohol's motivational properties in alcohol-preferring rats.

Paola Maccioni1, Daniela Pes, Noemi Fantini, Mauro A M Carai, Gian Luigi Gessa, Giancarlo Colombo.   

Abstract

gamma-Hydroxybutyric acid (GHB) reduces alcohol drinking, promotes abstinence from alcohol, suppresses craving for alcohol, and ameliorates alcohol withdrawal syndrome in alcoholics. At preclinical level, GHB suppresses alcohol withdrawal signs and alcohol intake in rats. The present study was designed to investigate whether GHB administration was capable of affecting alcohol's motivational properties (the possible animal correlate of human craving for alcohol) in selectively bred Sardinian alcohol-preferring rats. To this aim, rats were initially trained to lever press for alcohol (15%, vol/vol) under a procedure of operant, oral alcohol self-administration (fixed ratio 4 in 30-min daily sessions). Once responding for alcohol had stabilized, rats were divided into two groups and allocated to two independent experiments. Experiment 1 assessed the effect of GHB (0, 25, 50, and 100mg/kg, i.p.) on breakpoint for alcohol, defined as the lowest response requirement not achieved by each rat when exposed to a single-session progressive ratio schedule of reinforcement. Experiment 2 assessed the effect of GHB (0, 25, 50, and 100mg/kg, i.p.) on single-session extinction responding for alcohol (alcohol was absent and unreinforced responding was recorded). Breakpoint and extinction responding for alcohol are reliable indexes of alcohol's motivational strength. In Experiment 1, all doses of GHB reduced--by approximately 20% in comparison to saline-treated rats--breakpoint for alcohol. In Experiment 2, administration of 25, 50, and 100mg/kg GHB reduced--by approximately 25%, 40%, and 50%, respectively, in comparison to saline-treated rats--extinction responding for alcohol. Conversely, no dose of GHB altered breakpoint and extinction responding for sucrose (3%, wt/vol) in two independent subsets of Sardinian alcohol-preferring rats. Together, these data suggest that GHB administration specifically suppressed alcohol's motivational properties in Sardinian alcohol-preferring rats. These results are consistent with the anticraving properties of GHB observed in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358989     DOI: 10.1016/j.alcohol.2008.01.001

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  8 in total

1.  Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.

Authors:  Nathalie Pross; Alain Patat; Philippe Vivet; Michelle Bidaut; Nicolas Fauchoux
Journal:  Br J Clin Pharmacol       Date:  2015-08-11       Impact factor: 4.335

2.  Elevated reinforcing and motivational properties of alcohol at the end of the nocturnal period in sP rats.

Authors:  Paola Maccioni; Irene Lorrai; Maria Francesca Marras; Andrea Contini; Alessandro Capra; Gessica Piras; Pierluigi Caboni; Gian Luigi Gessa; Giancarlo Colombo
Journal:  Psychopharmacology (Berl)       Date:  2015-07-07       Impact factor: 4.530

3.  Reducing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on binge-like alcohol drinking in male mice and rats.

Authors:  Irene Lorrai; Chase Shankula; Jorge Marquez Gaytan; Tomoya Kawamura; Paola Maccioni; Claudia Mugnaini; Federico Corelli; Gian Luigi Gessa; Pietro Paolo Sanna; Giancarlo Colombo
Journal:  Psychopharmacology (Berl)       Date:  2021-11-23       Impact factor: 4.530

Review 4.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 5.  Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.

Authors:  Gillian M Keating
Journal:  Clin Drug Investig       Date:  2014-01       Impact factor: 2.859

6.  Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73.

Authors:  Antonella Loche; Francesco Simonetti; Carla Lobina; Mauro A M Carai; Giancarlo Colombo; M Paola Castelli; Domenico Barone; Roberto Cacciaglia
Journal:  Front Psychiatry       Date:  2012-02-14       Impact factor: 4.157

Review 7.  Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Authors:  Elizabeth M Burnette; Steven J Nieto; Erica N Grodin; Lindsay R Meredith; Brian Hurley; Karen Miotto; Artha J Gillis; Lara A Ray
Journal:  Drugs       Date:  2022-02-08       Impact factor: 9.546

8.  Suppression by γ-Hydroxybutyric Acid of "Alcohol Deprivation Effect" in Rats: Preclinical Evidence of its anti-Relapse Properties.

Authors:  Giancarlo Colombo; Mauro A M Carai; Gian Luigi Gessa
Journal:  Front Psychiatry       Date:  2012-11-05       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.